1. Home
  2. ALTI vs FULC Comparison

ALTI vs FULC Comparison

Compare ALTI & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$5.19

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$13.00

Market Cap

468.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
FULC
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
468.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ALTI
FULC
Price
$5.19
$13.00
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$16.38
AVG Volume (30 Days)
156.1K
2.6M
Earning Date
11-12-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$226,717,000.00
N/A
Revenue This Year
$19.78
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2752.05
52 Week Low
$2.33
$2.32
52 Week High
$5.45
$15.74

Technical Indicators

Market Signals
Indicator
ALTI
FULC
Relative Strength Index (RSI) 78.03 61.65
Support Level $4.29 $12.56
Resistance Level $5.45 $15.32
Average True Range (ATR) 0.33 1.27
MACD 0.13 0.30
Stochastic Oscillator 85.92 60.90

Price Performance

Historical Comparison
ALTI
FULC

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: